▶ 調査レポート

DNA検査キットのグローバル市場(~2027):頬スワブ、唾液

• 英文タイトル:DNA Test Kits Market Research Report by Sample Type, Application, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19

DNA Test Kits Market Research Report by Sample Type, Application, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19「DNA検査キットのグローバル市場(~2027):頬スワブ、唾液」(市場規模、市場予測)調査レポートです。• レポートコード:MRC2303H224
• 出版社/出版日:360iResearch / 2022年10月11日
• レポート形態:英語、PDF、241ページ
• 納品方法:Eメール(受注後2-3日)
• 産業分類:医療機器
• 販売価格(消費税別)
  Single User(1名利用、印刷可)¥742,350 (USD4,949)▷ お問い合わせ
  Enterprise License(企業利用、印刷可)¥1,492,350 (USD9,949)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
360iResearch社の当調査資料によると、2021年に683.87百万ドルであった世界のDNA検査キット市場規模は2022年に809.02百万ドルとなり、2027年までに年平均18.47%成長して1,891.39百万ドルまで拡大すると見込まれています。当書は、DNA検査キットの世界市場を対象とした調査・分析結果をまとめたものであり、序論、調査方法、エグゼクティブサマリー、市場概要、市場インサイト、検体種類別分析(頬スワブ、唾液)、用途別分析(祖先ルーツ検査、食事&栄養、疾病リスク分析、健康&フィットネス)、地域別分析(南北アメリカ、アメリカ、カナダ、ブラジル、アジア太平洋、日本、中国、インド、韓国、台湾、ヨーロッパ/中東/アフリカ、イギリス、ドイツ、フランス、ロシア、その他)、競争状況、企業情報などの内容を掲載しています。なお、当書内の企業情報としては、23andMe, Inc.、AB ANALITICA srl、Abbott Laboratories、Agilent Technologies Inc.、Ancestry.com LLC、Bio-Rad Laboratories, Inc.、BioNano Genomics, Inc.、CyberGene AB、FitnessGenes Limited、FUTURA GENETICS、Illumina, Inc.、Indus Health Plus Pvt Ltdなどが含まれています。

・序論
・調査方法
・エグゼクティブサマリー
・市場概要
・市場インサイト
・世界のDNA検査キット市場規模:検体種類別
- 頬スワブの市場規模
- 唾液の市場規模
・世界のDNA検査キット市場規模:用途別
- 祖先ルーツ検査における市場規模
- 食事&栄養における市場規模
- 疾病リスク分析における市場規模
- 健康&フィットネスにおける市場規模
・世界のDNA検査キット市場規模:地域別
- 南北アメリカのDNA検査キット市場規模
アメリカのDNA検査キット市場規模
カナダのDNA検査キット市場規模
ブラジルのDNA検査キット市場規模
...
- アジア太平洋のDNA検査キット市場規模
日本のDNA検査キット市場規模
中国のDNA検査キット市場規模
インドのDNA検査キット市場規模
韓国のDNA検査キット市場規模
台湾のDNA検査キット市場規模
...
- ヨーロッパ/中東/アフリカのDNA検査キット市場規模
イギリスのDNA検査キット市場規模
ドイツのDNA検査キット市場規模
フランスのDNA検査キット市場規模
ロシアのDNA検査キット市場規模
...
- その他地域のDNA検査キット市場規模
・競争状況
・企業情報

The Global DNA Test Kits Market size was estimated at USD 683.87 million in 2021 and expected to reach USD 809.02 million in 2022, and is projected to grow at a CAGR 18.47% to reach USD 1,891.39 million by 2027.

Market Statistics:
The report provides market sizing and forecast across 7 major currencies – USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.

Market Segmentation & Coverage:
This research report categorizes the DNA Test Kits to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Sample Type, the market was studied across Cheek Swab and Saliva.

Based on Application, the market was studied across Ancestry Testing, Diet & Nutrition, Disease Risk Assessment, and Health & Fitness.

Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:
We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for DNA Test Kits market considering the current update on the conflict and its global response.

Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the DNA Test Kits Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global DNA Test Kits Market, including 23andMe, Inc., AB ANALITICA srl, Abbott Laboratories, Agilent Technologies Inc., Ancestry.com LLC, Bio-Rad Laboratories, Inc., BioNano Genomics, Inc., CyberGene AB, FitnessGenes Limited, FUTURA GENETICS, Illumina, Inc., Indus Health Plus Pvt Ltd, Living DNA Ltd,, MyHeritage Ltd., Premas Lifesciences Pvt. Ltd., QIAGEN N.V., Roche Diagnostics, Siemens Healthcare GmbH, Thermo Fisher Scientific, and Veritas Genetics International Limited.

The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:
1. What is the market size and forecast of the Global DNA Test Kits Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global DNA Test Kits Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global DNA Test Kits Market?
4. What is the competitive strategic window for opportunities in the Global DNA Test Kits Market?
5. What are the technology trends and regulatory frameworks in the Global DNA Test Kits Market?
6. What is the market share of the leading vendors in the Global DNA Test Kits Market?
7. What modes and strategic moves are considered suitable for entering the Global DNA Test Kits Market?

レポート目次

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increase in the incidences of genetic, infectious, and chronic diseases
5.1.1.2. Implementation of personalized medicine applications
5.1.1.3. Growing demand for in-vitro fertilization and prenatal testing
5.1.2. Restraints
5.1.2.1. High cost involved in R&D pertaining to the introduction of new techniques
5.1.3. Opportunities
5.1.3.1. Introduction of innovative technologies to advance genome profiling
5.1.3.2. Availability of direct-to-consumer (DTC) testing services
5.1.4. Challenges
5.1.4.1. Lack of awareness of genetic counseling
5.2. Cumulative Impact of COVID-19

6. DNA Test Kits Market, by Sample Type
6.1. Introduction
6.2. Cheek Swab
6.3. Saliva

7. DNA Test Kits Market, by Application
7.1. Introduction
7.2. Ancestry Testing
7.3. Diet & Nutrition
7.4. Disease Risk Assessment
7.5. Health & Fitness

8. Americas DNA Test Kits Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States

9. Asia-Pacific DNA Test Kits Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
9.13. Vietnam

10. Europe, Middle East & Africa DNA Test Kits Market
10.1. Introduction
10.2. Denmark
10.3. Egypt
10.4. Finland
10.5. France
10.6. Germany
10.7. Israel
10.8. Italy
10.9. Netherlands
10.10. Nigeria
10.11. Norway
10.12. Poland
10.13. Qatar
10.14. Russia
10.15. Saudi Arabia
10.16. South Africa
10.17. Spain
10.18. Sweden
10.19. Switzerland
10.20. Turkey
10.21. United Arab Emirates
10.22. United Kingdom

11. Competitive Landscape
11.1. FPNV Positioning Matrix
11.1.1. Quadrants
11.1.2. Business Strategy
11.1.3. Product Satisfaction
11.2. Market Ranking Analysis, By Key Player
11.3. Market Share Analysis, By Key Player
11.4. Competitive Scenario
11.4.1. Merger & Acquisition
11.4.2. Agreement, Collaboration, & Partnership
11.4.3. New Product Launch & Enhancement
11.4.4. Investment & Funding
11.4.5. Award, Recognition, & Expansion

12. Company Usability Profiles
12.1. 23andMe, Inc.
12.1.1. Business Overview
12.1.2. Key Executives
12.1.3. Product & Services
12.2. AB ANALITICA srl
12.2.1. Business Overview
12.2.2. Key Executives
12.2.3. Product & Services
12.3. Abbott Laboratories
12.3.1. Business Overview
12.3.2. Key Executives
12.3.3. Product & Services
12.4. Agilent Technologies Inc.
12.4.1. Business Overview
12.4.2. Key Executives
12.4.3. Product & Services
12.5. Ancestry.com LLC
12.5.1. Business Overview
12.5.2. Key Executives
12.5.3. Product & Services
12.6. Bio-Rad Laboratories, Inc.
12.6.1. Business Overview
12.6.2. Key Executives
12.6.3. Product & Services
12.7. BioNano Genomics, Inc.
12.7.1. Business Overview
12.7.2. Key Executives
12.7.3. Product & Services
12.8. CyberGene AB
12.8.1. Business Overview
12.8.2. Key Executives
12.8.3. Product & Services
12.9. FitnessGenes Limited
12.9.1. Business Overview
12.9.2. Key Executives
12.9.3. Product & Services
12.10. FUTURA GENETICS
12.10.1. Business Overview
12.10.2. Key Executives
12.10.3. Product & Services
12.11. Illumina, Inc.
12.11.1. Business Overview
12.11.2. Key Executives
12.11.3. Product & Services
12.12. Indus Health Plus Pvt Ltd
12.12.1. Business Overview
12.12.2. Key Executives
12.12.3. Product & Services
12.13. Living DNA Ltd,
12.13.1. Business Overview
12.13.2. Key Executives
12.13.3. Product & Services
12.14. MyHeritage Ltd.
12.14.1. Business Overview
12.14.2. Key Executives
12.14.3. Product & Services
12.15. Premas Lifesciences Pvt. Ltd.
12.15.1. Business Overview
12.15.2. Key Executives
12.15.3. Product & Services
12.16. QIAGEN N.V.
12.16.1. Business Overview
12.16.2. Key Executives
12.16.3. Product & Services
12.17. Roche Diagnostics
12.17.1. Business Overview
12.17.2. Key Executives
12.17.3. Product & Services
12.18. Siemens Healthcare GmbH
12.18.1. Business Overview
12.18.2. Key Executives
12.18.3. Product & Services
12.19. Thermo Fisher Scientific
12.19.1. Business Overview
12.19.2. Key Executives
12.19.3. Product & Services
12.20. Veritas Genetics International Limited
12.20.1. Business Overview
12.20.2. Key Executives
12.20.3. Product & Services

13. Appendix
13.1. Discussion Guide
13.2. License & Pricing